deininger lab banner

Overview

Deininger/O'Hare Lab

Welcome to the Deininger/O'Hare Lab

The Deininger/O'Hare lab expertise is in the study of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecularly targeted therapies. We are especially interested in understanding the molecular mechanisms of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer.

deininger-lab-group

  

  

For more information about our lab, contact Tony Pomicter:
tony.pomicter@hci.utah.edu or 801-587-4077